Nevro's Senza spinal cord stimulation system for chronic pain gets FDA approval

Oct. 13, 2022 5:32 AM ETNevro Corp. (NVRO)By: Ravikash, SA News Editor

FDA Approved Products or Drugs

Olivier Le Moal

  • The U.S. Food and Drug Administration (FDA) approved Nevro's (NYSE:NVRO) Senza HFX iQ spinal cord stimulation (SCS) system.
  • Senza HFX iQ is the first and only Artificial Intelligence (AI)-based SCS system which learns from patients, the company said in

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.